These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 12063621)

  • 1. [Pulmonary metabolism of nitric oxide (NO) in patients with cystic fibrosis].
    Grasemann H; Ratjen F
    Pneumologie; 2002 Jun; 56(6):376-81. PubMed ID: 12063621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide in cystic fibrosis.
    de Winter-de Groot KM; van der Ent CK
    J Cyst Fibros; 2005 Aug; 4 Suppl 2():25-9. PubMed ID: 15982933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced exhaled NO is related to impaired nasal potential difference in patients with cystic fibrosis.
    Texereau J; Fajac I; Hubert D; Coste J; Dusser DJ; Bienvenu T; Dall'Ava-Santucci J; Dinh-Xuan AT
    Vascul Pharmacol; 2005 Dec; 43(6):385-9. PubMed ID: 16182611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-inflammatory effect of miglustat in bronchial epithelial cells.
    Dechecchi MC; Nicolis E; Norez C; Bezzerri V; Borgatti M; Mancini I; Rizzotti P; Ribeiro CM; Gambari R; Becq F; Cabrini G
    J Cyst Fibros; 2008 Nov; 7(6):555-65. PubMed ID: 18815075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What's new in CF airway inflammation: an update.
    Ratjen F
    Paediatr Respir Rev; 2006; 7 Suppl 1():S70-2. PubMed ID: 16798601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is it go or NO go for S-nitrosylation modification-based therapies of cystic fibrosis transmembrane regulator trafficking?
    Zeitlin PL
    Mol Pharmacol; 2006 Oct; 70(4):1155-8. PubMed ID: 16877677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Airway nitric oxide levels in cystic fibrosis patients are related to a polymorphism in the neuronal nitric oxide synthase gene.
    Grasemann H; Knauer N; Büscher R; Hübner K; Drazen JM; Ratjen F
    Am J Respir Crit Care Med; 2000 Dec; 162(6):2172-6. PubMed ID: 11112133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysfunction of the non-neuronal cholinergic system in the airways and blood cells of patients with cystic fibrosis.
    Wessler I; Bittinger F; Kamin W; Zepp F; Meyer E; Schad A; Kirkpatrick CJ
    Life Sci; 2007 May; 80(24-25):2253-8. PubMed ID: 17346753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Early bronchial inflammation in cystic fibrosis].
    Puchelle E
    J Soc Biol; 2002; 196(1):29-35. PubMed ID: 12134630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of the cystic fibrosis gene in the lungs].
    Heijerman HG; de Jonge HR
    Ned Tijdschr Geneeskd; 2004 Apr; 148(17):816-9. PubMed ID: 15141646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationships between cystic fibrosis transmembrane conductance regulator, extracellular nucleotides and cystic fibrosis.
    Marcet B; Boeynaems JM
    Pharmacol Ther; 2006 Dec; 112(3):719-32. PubMed ID: 16828872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strain-dependent pulmonary gene expression profiles of a cystic fibrosis mouse model.
    Haston CK; Cory S; Lafontaine L; Dorion G; Hallett MT
    Physiol Genomics; 2006 Apr; 25(2):336-45. PubMed ID: 16614460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased arylsulfatase B activity in cystic fibrosis cells following correction of CFTR.
    Bhattacharyya S; Look D; Tobacman JK
    Clin Chim Acta; 2007 May; 380(1-2):122-7. PubMed ID: 17324393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purinergic signaling underlies CFTR control of human airway epithelial cell volume.
    Braunstein GM; Zsembery A; Tucker TA; Schwiebert EM
    J Cyst Fibros; 2004 Jun; 3(2):99-117. PubMed ID: 15463893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developmental paradigm for early features of cystic fibrosis.
    Larson JE; Cohen JC
    Pediatr Pulmonol; 2005 Nov; 40(5):371-7. PubMed ID: 15830387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of IKK and ERK pathways in intrinsic inflammation of cystic fibrosis airways.
    Verhaeghe C; Remouchamps C; Hennuy B; Vanderplasschen A; Chariot A; Tabruyn SP; Oury C; Bours V
    Biochem Pharmacol; 2007 Jun; 73(12):1982-94. PubMed ID: 17466952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered terminal glycosylation and the pathophysiology of CF lung disease.
    Rhim AD; Stoykova LI; Trindade AJ; Glick MC; Scanlin TF
    J Cyst Fibros; 2004 Aug; 3 Suppl 2():95-6. PubMed ID: 15463936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suitability of oligonucleotide-mediated cystic fibrosis gene repair in airway epithelial cells.
    de Semir D; Nadal M; González JR; Larriba S; Avinyó A; Nunes V; Casals T; Estivill X; Aran JM
    J Gene Med; 2003 Jul; 5(7):625-39. PubMed ID: 12825202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the cystic fibrosis transmembrane conductance regulator in internalization of Pseudomonas aeruginosa by polarized respiratory epithelial cells.
    Darling KE; Dewar A; Evans TJ
    Cell Microbiol; 2004 Jun; 6(6):521-33. PubMed ID: 15104594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression of pulmonary hyperinflation and trapped gas associated with genetic and environmental factors in children with cystic fibrosis.
    Kraemer R; Baldwin DN; Ammann RA; Frey U; Gallati S
    Respir Res; 2006 Nov; 7(1):138. PubMed ID: 17137500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.